AMPH (Amphastar Pharmaceuticals) Earnings per share growth rate in current year
Global logistics disruptions and currency risks are weighing on the international shipments of Amphastar Pharmaceuticals (AMPH). The year-over-year EPS growth trend captures these challenges, with the -1.50 level serving as a critical benchmark. However, the company is offsetting this pressure by monopolizing the complex injectables market and scaling sales of its diabetes brands, leveraging high technical production complexity to consistently exercise pricing power within hospitals.
Analytical breakdowns and data insights for company Amphastar Pharmaceuticals (AMPH)
- stock price and consensus target price:
- business market valuation indicators:
- balance sheet equity data:
- debt and liquidity details:
Total Debt to Equity Ratio Amphastar Pharmaceuticals|AMPH - Long-Term Debt to Equity|Current Liabilities to Equity Amphastar Pharmaceuticals, Inc.|AMPH - Company Aggregate Debts|Debt to Net Assets Ratio Amphastar Pharmaceuticals|AMPH - Company Long-Term Debts|Company Short-Term Debts Amphastar Pharmaceuticals|Interim Coverage Ratio amphastar.com
- net income and valuation multiples indicators:
AMPH - Net Income|Future Net Profit Amphastar Pharmaceuticals|AMPH - P/E Multiple|Forward P/E Multiple amphastar.com|AMPH - Price/Earnings to Growth Ratio|Business Value to Operating Income Before Depreciation Amphastar Pharmaceuticals Inc|AMPH - Operating profit before deduction of amortization|Earnings per share for the trailing year Amphastar Pharmaceuticals|AMPH - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months amphastar.com|AMPH - Earnings growth in current year|Expected earnings per share trend next year Amphastar Pharmaceuticals
- sales volume and revenue information:
Fundamental valuation:Amphastar (AMPH)
Assessing the investment attractiveness of Amphastar Pharmaceuticals (AMPH) requires an analysis of the efficiency of its highly automated production lines, which minimize costs through robotics. The trend captured by the measurable YoY EPS growth demonstrates the percentage change in net income per share compared to last year, allowing investors to filter out market noise and determine the actual capital stability of the issuer.
Direct competitors
Earnings per share growth rate in current year Haleon Corp (HLN)|KVUE (Kenvue Inc) - Earnings growth in current year|Earnings per share growth rate in current year veronapharma.com VRNA|Earnings per share growth in current year Jyong Biotech (MENS)|LGND (Ligand Pharmaceuticals Incorporated) - Earnings per share increase in current year|Earnings growth in current year AMRX (Amneal Pharmaceuticals, Inc.)|PRGO (Perrigo Company) - Earnings per share trend in current year|ALVO - Earnings per share growth in current year|Expected net earnings per share growth this year liquidia.com LQDA|Galapagos (GLPG) - Earnings per share growth in current year|ANIP - Expected net earnings per share growth this year|Earnings per share growth in current year MannKind Corporation|Pacira Corp (PCRX) - Expected net earnings per share growth this year|Earnings per share growth in current year ARS Pharma (SPRY)|Earnings growth in current year Theravance Biopharma, Inc. (TBPH)|Aquestive Therapeutics - Net earnings per share growth this year|Earnings per share increase in current year SCPH|Tectonic Therapeutic Inc. - Earnings growth in current year|Earnings per share trend in current year TNXP|SXTC (China SXT Pharmaceuticals) - Net earnings per share growth this year|Eupraxia Pharmaceuticals (EPRX) - Earnings growth in current year|Earnings per share growth in current year BioHarvest Sciences, Inc.|EXOZ: Earnings per share increase in current year|Earnings growth in current year ORMP|ENTX - Earnings per share growth rate in current year|Earnings per share growth in current year MindWalk Holdings, Inc. HYFT|Earnings growth in current year abvcpharma.com ABVC|CPIX - Earnings per share growth in current year|Earnings per share trend in current year QNTM|FGEN (FibroGen Corporation) - Net earnings per share growth this year|Net earnings per share growth this year Telomir Pharma|Net earnings per share growth this year RANI|Earnings per share growth rate in current year synergychc.com SNYR|Earnings per share growth in current year Rallybio Corp (RLYB)|LEXX - Earnings per share growth rate in current year|Pulmatrix Inc - Net earnings per share growth this year|Earnings per share increase in current year PTHL|Aptorum Group Ltd - Earnings growth in current year|Expected net earnings per share growth this year Lyra Therapeutics LYRA|IBO: Earnings growth in current year|TNFA (TNF Pharma) - Earnings per share growth in current year|Earnings per share growth in current year cbdmd.com|Earnings per share growth this year PRFX (PainReform Corp)|Earnings growth in current year CYTO|Net earnings per share growth this year Lipella Pharmaceuticals LIPO|Earnings per share growth in current year OptiNose OPTN|Pieris Pharmaceuticals Inc - Earnings per share growth in current year|Procaps Group Corp - Earnings growth in current year|Expected net earnings per share growth this year Petros Pharma PTPI|Qilian International Holding Group Limited (QLI) - Earnings per share growth in current year|ACELYRIN (SLRN) - Earnings growth in current year|Earnings per share growth in current year TFF Pharmaceuticals
